It has been observed that peripheral plasmablasts in RA patients can produce ACPA, and approximately 63% of these antibodies cross-react with P. gingivalis outer membrane antigens and/or citrullinated enolase (152). Here, PRTN3 is linked to rheumatoid arthritis.